Publications

Potency and bactericidal activity of iclaprim against Gram-positive isolates. by Sader HS, Fritsche TR and Jones RN published in Antimicrob. Agents Chemother. 2009; 53 (5): 2171-2175

In vitro potency of doripenem tested against an international collection of rarely isolated bacterial pathogens by Jones RN, Bell JM, Sader HS, Turnidge JD and Stilwell MG published in Diagn. Microbiol. Infect. Dis. 2009; 63 (4): 434-439

Antimicrobial activity of doripenem tested against prevalent Gram-positive pathogens: Results from a global surveillance study (2003-2007). by Fritsche TR, Sader HS, Stillwell MG, Jones RN published in Diagn. Microbiol. Infect. Dis. 2009; 63 (4): 440-446

Antimicrobial activities of doripenem and other carbapenems against Pseudmonas aeruginosa, other nonfermentative bacilli, and Aeromonas spp. by Castanheira M, Jones RN, Livermore DM published in Diagn. Microbiol. Infect. Dis. 2009; 63 (4): 426-433

Doripenem activity tested against a global collection of Enterobacteriaceae, including isolates resistant to other extended-spectrum agents. by Mendes RE, Rhomberg PR, Bell JM, Turnidge JD, Sader HS published in Diagn. Microbiol. Infect. Dis. 2009; 63 (4): 415-425

Antimicrobial activity of daptomycin and selected comparators tested against bloodstream Staphylococcus aureus isolates from hemodialysis patients. by Sader HS, Fritsche TR, Jones RN published in Int. J. Infect. Dis. 2009; 13 (2): 291-295

In vitro activity of iclaprim and comparison agents tested against Neisseria gonorrhoeae including medium growth supplement effects. by Jones RN, Biedenbach DJ and Sader HS published in Diagn. Microbiol. Infect. Dis. 2009; 63 (3): 339-341

Carbapenem resistance among Pseudmonas aeruginosa strains form India: Evidence for nationwide endemicity of multiple metallo-beta-lactamase clones (VIM-2, -5, -6, and -11 and the newly characterized VIM-18). by Castanheira M, Bell JM, Turnidge JD, Mathai D and Jones RN published in Antimicrob. Agents Chemother. 2009; 53 (3): 1225-1227

Antimicrobial activity of prulifloxacin tested against a worldwide collection of gastroenteritis-producing pathogens, including those causing traveler’s diarrhea. by Fritsche TR, Biedenbach DJ and Jones RN published in Antimicrob. Agents Chemother. 2009; 53 (3): 1221-1224

Codetection of bla_OXA-23-like gene (bla_OXA-133) and bla_OXA-58 in Acintobacter radioresistens: Report from the SENTRY Antimicrobial Surveillance Program. by Mendes RE, Bell JM, Turnidge JD, Castanheira M, Deshpande LM and Jones RN published in Antimicrob. Agents Chemother. 2009; 53 (2): 843-844

A global evaluation of voriconazole activity tested against recent clinical isolates of Candida spp. by Diekema DJ, Messer SA, Hollis RJ, Boyken L, Tendolkar S, Kroeger J, Jones RN and Pfaller MA published in Diagn. Microbiol. Infect. Dis. 2009; 233 (2): 233-236

Emergence and widespread dissemination of OXA-23, -24/40 and -58 carbapenemased among Acinetobacter spp. in Asia-Pacific nations: Report from the SENTRY Surveillance Program. by Mendes RE, Bell JM, Turnidge JD, Castanheira M, and Jones RN published in J. Antimicrob. Chemother. 2009; 63 (1): 55-59

Case report of Aurantimonas altamirensis bloodstream infection. by Mendes RE, Denys GA, Fritsche TR and Jones RN published in J. Clin. Microbiol. 2009; 47 (2): 514-515

Antimicrobial Activity of Daptomycin and Comparators Tested Against S. aureus from 20 USA Hospitals in 2005-2008: Evaluation of Potency Trends, Lead author: Sader HS, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Activity of Oritavancin Tested Against Contemporary Gram-Positive Pathogens Submitted to a Global Surveillance Program (2008), Lead author: Fritsche TR, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Antimicrobial Activity of Telavancin Tested Against Contemporary Gram-Positive Pathogens: Results from an International Surveillance Program (2007), Lead author: Fritsche TR, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Ceftobiprole Activity Tested Against North American Enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter spp. in 2005-2007, Lead author: Fritsche TR, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Ceftaroline Activity Tested Against Organisms Causing Skin and Skin Structure Infections (SSSI) Isolated in USA and European Medical Centers in 2008, Lead author: Sader HS, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

In Vitro Activity of Ceftaroline (CPT) in Combination Against Extended-Spectrum ß-lactamase (ESBL) Producing Gram-Negative (GN) Bacteria, Lead author: Vidaillac, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

In Vitro Activity of Dalbavancin Tested Against a Worldwide Collection of 81,677 Gram-Positive Bacterial Isolates, Lead author: Biedenbach DJ, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Activity of Omiganan, a Novel Peptide, Tested Against Contemporary Gram-Negative Pathogens: Results from an International Surveillance Program (2008), Lead author: Fritsche TR, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Antimicrobial Activity of Ceftaroline (CPT) Tested Against Contemporary (2008) Bacteria Isolated from Community-Acquired Respiratory Tract Infections (CARTI), Including Oxacillin-Resistant S. aureus (MRSA), Lead author: Sader HS, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

The Changing Face of Oxacillin-Resistant Staphylococcus aureus in the Asia-Pacific Region: A SENTRY Report, 1998 -2007, Lead author: Turnidge JD, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Evaluation of Vancomycin (VAN) Potency Trends (&quotCreep&quot) Against Methicillin-Resistant S. aureus Collected in Nine United States Hospitals Over Five Years (2002- 2006), Lead author: Sader HS, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Antimicrobial Susceptibility of Clinical Strains of KPC-Producing and CTX-M-Producing Enterobacteriaceae: A Global Analysis, Lead author: Sader HS, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Acquired Carbapenem Hydrolyzing ß-Lactamases Among Clinical Strains of Acinetobacter spp. from Latin America: Report from the SENTRY Antimicrobial Program, Lead author: Gales AC, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Rapid Emergence and Spread of Acinetobacter spp. (ASP) Producing Carbapenem-Hydrolyzing Oxacillinases (CHCDß): Report from the SENTRY Program, Lead author: Mendes RE, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Outbreak Caused by a Clone of OXA-23- or OXA-58-Producing Acinetobacter baumannii (ACB) in a Rome Hospital: First Outbreak of bla_OXA-23-Carrying ACB in Italy, Lead author: Mendes RE, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Coproduction of OXA-58 and IMP-1 Carbapenemases in an Acinetobacter lwoffii (AL), Lead author: Mendes RE, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

In Vitro Activity of Tigecycline Tested against Acinetobacter spp. Producing Carbapenem-Hydrolyzing Oxacillinases: a Global Study of 320 Strains, Lead author: Sader HS, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

An Extended Aminoglycoside Resistance Profile in Isolates of Enterobacteriaceae from the Sentry Surveillance Program in the Asia-Pacific Region, 2007, Lead author: Bell JM, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Enterobacter Species as a Major Reservoir for Extended-Spectrum ß-lactamase Encoding and Related Genes in the Sentry Asia-Pacific Region 2006, Lead author: Bell JM, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Comparison of Broth Microdilution and Etest Method Results when Testing Vancomycin (VAN) and Daptomycin (DAP) Against Methicillin-Resistant S. aureus (MRSA) from 9 USA Hospitals, Lead author: Sader HS, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Evaluation of the Accuracy of the Etest Macromethod for Detection of Heterogeneous Vancomycin-Intermediate S. aureus (hVISA) Strains, Lead author: Sader HS, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

A Multi-Site Study of an 18-24h Susceptibility System to the CLSI Microdilution Method for Gram-Negative and Gram-Positive Organisms vs. Doxycycline, Lead author: Killian SB, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

A Multi-Site Study of an 18-24h Susceptibility System to the CLSI Microdilution Method for Acinetobacter spp., Pseudomonas spp. and Pseudomonas aeruginosa vs. Colistin(COL) and Polymixin B (POL), Lead author: Holliday, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Proposed MIC Quality Control Ranges for CEM-101 Using the CLSI Multi-Laboratory M23-A2 Study Design, Lead author: Rhomberg PR, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Tigecycline In Vitro Susceptibility Test Accuracy Using Three Methods and USA-FDA Interpretive Criteria When Testing Japanese Clinical Isolates (2007), Lead author: Jones RN, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

TR-700, a Novel Oxazolidinone, Tested Against Linezolid-Resistant Gram-positive Species with Well-Characterized Resistance Mechanisms, Lead author: Jones RN, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Novel Nanoemulsion Antimicrobials Tested Against Nine Gram-Positive Species, Lead author: Sutcliffe, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Antimicrobial Activity of Nanoemulsions Tested Against Seven Gram-Negative Species, Lead author: Fritsche TR, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Antimicrobial Characterization of CEM-101 Activity Against 331 Respiratory Tract Pathogens Including Multidrug-Resistant Pneumococcal Serogroup 19A (MDR-19A) Isolates, Lead author: Jones RN, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Antimicrobial Characterization of CEM-101: Activity Against Enterococci, Uncommon Gram-positive Pathogens, N. gonorrhoeae and Anaerobes, Lead author: Jones RN, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Antimicrobial Characterization of CEM-101: Potential Application Against Species Causing Enteritis/Gastroenteritis, Lead author: Jones RN, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Antimicrobial Characterization of CEM-101: PAE, Bactericidal Activity and Combinations, Lead author: Jones RN, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Antimicrobial Characterization of CEM-101: Single Step, Selection by Passaging and Inducible Resistances, Lead author: Jones RN, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Assessment of CEM-101 Susceptibility Testing Conditions and Optimization of Disk Diffusion Methods, Lead author: Jones RN, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Proposed Quality Control (QC) Parameters for Disk Diffusion (DD) Tests with Anidulafungin, Lead author: Jones RN, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Voriconazole Activity Against Aspergillus spp: Eight Years of Global Surveillance, Lead author: Diekema DJ, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Activity of Anidulafungin and Other Antifungal Agents: Results from an International Fungal Surveillance Program (2006-2007), Lead author: Fritsche TR, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC